QA: ESSA Pharma Inc. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001633932_2022_ESSA_Pharma_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001633932')"}

Graph

Absolute values for 0001633932, ESSA Pharma Inc.

  xvar xval
0 AssetsCurrent 197,598,077
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 567,741
4 LiabilitiesCurrent 3,929,663
5 LiabilitiesNoncurrent 210,251
6 remainder_Liabilities 20,352
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,884,581
9 ResearchAndDevelopmentExpense 24,258,989
10 remainder_Expenses -12,129
11 remainder_Revenues 0
12 remainder_NetIncome 325,980
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 198,165,818
1 Liabilities 4,160,266
2 Expenses 37,131,441
3 Revenues 0
4 StockholdersEquity 194,005,552
5 NetIncome -36,805,461
6 ComprehensiveNetIncome -36,805,461
7 BaseVar 119,891,752
8 EconomicCapitalRatio 2.93

Edgar->Model Mapping

Feature Distribution

Change over Time